Identification et caractérisation du polymorphisme génétique des cytochromes P450 4A11 et 4A22 (CYP4A11 et CYP4A22) et de la glycine N-acyltransférase (GLYAT)

Identification et caractérisation du polymorphisme génétique des cytochromes P450 4A11 et 4A22 (CYP4A11 et CYP4A22) et de la glycine N-acyltransférase (GLYAT)

Show other versions (1)

Afin de s'adapter à son environnement chimique, l'organisme a développé au cours de l'évolution des systèmes enzymatiques capables de transformer de nombreuses molécules étrangères ou xénobiotiques (médicaments, composés toxiques, carcinogènes...), le plus souvent de nature hydrophobe...

Full description

Bibliographic Details
Main Author:	Lino Cardenas, Christian Lacks
Language:	fra
Published:	Université du Droit et de la Santé - Lille II 2010
Subjects:	[SDV] Life Sciences [SDV] Sciences du Vivant Cytochrome P-450 CYP4A11 Cytochrome P 450 CYP4A22 Glycine N-acyltransférase (GLYAT)
Online Access:	http://tel.archives-ouvertes.fr/tel-00630109 http://tel.archives-ouvertes.fr/docs/00/63/01/09/PDF/ThA_se_-_Christian_Lino.pdf

Similar Items

Identification et caractérisation du polymorphisme génétique des cytochromes P450 4A11 et 4A22 (CYP4A11 et CYP4A22) et de la glycine N-acyltransférase (GLYAT)
by: Lino Cardenas, Christian Lacks
Published: (2010)

CYP3A4∗22 Genotyping in Clinical Practice: Ready for Implementation?
by: Tessa A. M. Mulder, et al.
Published: (2021-07-01)

Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina
by: Sabina Semiz, et al.
Published: (2011-02-01)

Genetic polymorphism in dextromethorphan metabolism by CYP2D6 and CYP3A4 enzyme isoforms / Mthokozisi Muziwandile Nkosingiphile Mgwabi
by: Mgwabi, Mthokozisi Muziwandile Nkosingiphile
Published: (2009)

Genetic polymorphism in dextromethorphan metabolism by CYP2D6 and CYP3A4 enzyme isoforms / Mthokozisi Muziwandile Nkosingiphile Mgwabi
by: Mgwabi, Mthokozisi Muziwandile Nkosingiphile
Published: (2009)

L'utilisation de la dompéridone comme substrat marqueur de l'activité in vitro des CYP3A4 et CYP3A5
by: Michaud, Véronique
Published: (2016)

In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9
by: Serena Nembri, et al.
Published: (2016-06-01)

The Making of a CYP3A Biomarker Panel for Guiding Drug Therapy
by: Danxin Wang, et al.
Published: (2012-10-01)

CYP3A4 isoenzyme phenotyping for personalisation of pharmacotherapy
by: E. A. Egorenkov, et al.
Published: (2018-02-01)

Three new shRNA expression vectors targeting the CYP3A4 coding sequence to inhibit its expression
by: Siyun Xu, et al.
Published: (2014-10-01)

Pharmacogenomics of cytochrome P450 3A4 (CYP3A4): recent progress towards the missing heritability problem
by: Kathrin eKlein, et al.
Published: (2013-02-01)

Étude biophysique du cytochrome P4503A4 humain
by: Plante, Mélanie
Published: (2007)

CYP1A1 and CYP2E1 polymorphism frequencies in a large Brazilian population
by: Renata dos Santos Coura, et al.
Published: (2007-01-01)

Investigations of the biocatalytic activity of human P450 2D6
by: Zhao, Jin, 1975-
Published: (2007)

Crystal Structure of CYP2B6 in Complex with an Efavirenz Analog
by: Manish B. Shah, et al.
Published: (2018-03-01)

CYP4Z1 und CYP4Z2P: Identifizierung neuer Mitglieder der humanen Cytochrom P450 Familie mit präferentieller Expression in Brustdrüsengewebe und Mammakarzinom
by: Rieger, Michael A.
Published: (2004)

Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug–Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach
by: Laura Maria Fuhr, et al.
Published: (2021-02-01)

Genetic variations in the drug metabolizing enzyme, CYP2E1, among various ethnic populations of Pakistan
by: Sagheer Ahmed, et al.
Published: (2020-08-01)

Pharmacokinetics of diclofenac in healthy controls with wild-type phenotype for CYP2C9 shows metabolism variability
by: M. Martín-De Saro, et al.
Published: (2017-04-01)

Modeling Chemical Interaction Profiles: I. Spectral Data-Activity Relationship and Structure-Activity Relationship Models for Inhibitors and Non-inhibitors of Cytochrome P450 CYP3A4 and CYP2D6 Isozymes
by: Richard D. Beger, et al.
Published: (2012-03-01)

Pharmacogenomics of CYP2C9: Functional and Clinical Considerations
by: Ann K. Daly, et al.
Published: (2017-12-01)

Interações farmacológicas entre medicações clínicas e psiquiátricas Drug interactions among clinical and psychiatric drugs
by: Marco Antonio Marcolin, et al.
Published: (2004-01-01)

Isolation and characterization of the full-length cDNA encoding a member of a novel cytochrome p450 family (CYP320A1) from the tropical freshwater snail, Biomphalaria glabrata, intermediate host for Schistosoma mansoni
by: Anne E Lockyer, et al.
Published: (2005-05-01)

Évaluation de la génotoxicité des contaminants environnementaux, production de lignées bio-senseurs et mesure de l'activité enzymatique du cytochrome P450 2E1 dans les cellules d'hépatome humain HepaRG
by: Quesnot, Nicolas
Published: (2015)

CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People
by: Yuanxia Cui, et al.
Published: (2020-08-01)

Etude et applications de nouveaux modèles géométriques des canaux d'accès au site actif de certains cytochromes P450 humains par des ligands volumineux
by: Benkaidali, Lydia
Published: (2016)

ROLE OF THE CYP1A2 GENE POLYMORPHISM ON EARLY AGEING FROM OCCUPATIONAL EXPOSURE
by: Eshkoor Sa., et al.
Published: (2013-12-01)

Expression of CYP2A3 mRNA and its regulation by 3-methylcholanthrene, pyrazole, and ß-ionone in rat tissues
by: A.B. Robottom-Ferreira, et al.
Published: (2003-07-01)

The genetic profiles of CYP1A1, CYP1A2 and CYP2E1 enzymes as susceptibility factor in xenobiotic toxicity in Turkish population
by: Merve Arici, et al.
Published: (2017-02-01)

Relationship between MspI polymorphism of CYP1A1 gene and the risk of endometriosis in an Iranian population: A case-control study
by: Azam Babaki, et al.
Published: (2018-10-01)

Study of the hepatic stability and the therapeutic potential of novel antimitotic prodrugs selective for CYP1A1-expressing breast cancer cells
by: Zarifi Khosroshahi, Mitra, et al.
Published: (2019)

Identification of CYP2E1-dependent genes involved in carbon tetrachloride-induced hepatotoxicity.
Published: (2001)

Prevalence of CYP2C19 Genetic Polymorphism among Normal People and Patients with Hepatic Diseases
by: Z Hashemizadeh, et al.
Published: (2018-01-01)

Molecular Dynamics Simulations of a Cytochrome P450 from <i>Tepidiphilus thermophilus</i> (P450-TT) Reveal How Its Substrate-Binding Channel Opens
by: Abayomi S. Faponle, et al.
Published: (2021-06-01)

Characterization of Arabidopsis CYP79C1 and CYP79C2 by Glucosinolate Pathway Engineering in Nicotiana benthamiana Shows Substrate Specificity Toward a Range of Aliphatic and Aromatic Amino Acids
by: Cuiwei Wang, et al.
Published: (2020-02-01)

Optimisation des conditions réactionnelles et création de nouveaux mutants à grande performance du cytochrome p450 BM3 CYP102A1 utilisant les cofacteurs alternatifs NADH et N-benzyl-1,4-dihydronicotinamide
by: Vincent, Thierry
Published: (2020)

Rifampicin does not significantly affect the expression of Small heterodimer partner (SHP) in primary human hepatocytes
by: Petr ePavek, et al.
Published: (2012-01-01)

Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification
by: Kata W. Pedersen, et al.
Published: (2021-10-01)

Cytochrome P450 2A6 whole-gene deletion ( CYP2A6*4 ) polymorphism reduces risk of lung cancer: A meta-analysis
by: Fadzrul H. Johani, et al.
Published: (2020-06-01)

CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population
by: Merve Arici, et al.
Published: (2017-03-01)